Lucchino David L. 4
4 · Korro Bio, Inc. · Filed Nov 27, 2023
Insider Transaction Report
Form 4
Korro Bio, Inc.KRRO
Lucchino David L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-11-22$35.99/sh−110$3,959→ 23,196 total - Sale
Common Stock
2023-11-22$36.74/sh−230$8,450→ 22,966 total - Sale
Common Stock
2023-11-22$37.98/sh−614$23,322→ 22,352 total - Sale
Common Stock
2023-11-22$38.82/sh−202$7,842→ 22,150 total
Footnotes (5)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance restricted stock units, and does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.26 to $36.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.40 to $37.20, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.52 to $38.35, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.62 to $39.015, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.